Evidence map›Paper›PMID 33465507›Full record

ArticleActa biomaterialia2021

Hydrogel microspheres for spatiotemporally controlled delivery of RNA and silencing gene expression within scaffold-free tissue engineered constructs.

Alexandra McMillan, Minh Khanh Nguyen, Cong Truc Huynh, Samantha M Sarett, Peilin Ge, Melanie Chetverikova, Kien Nguyen, David Grosh, Craig L Duvall, Eben Alsberg

Open access · greenAbstract read
In one paragraph

Article in Acta biomaterialia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Millimeter-Scale Dual-Opposing RNA-Gradient Hydrogel for Interfacial Gene Silencing.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Tailoring biomaterials for vaccine delivery.Journal of nanobiotechnology · 2024
    Review
  8. Review
  9. 3D Bioprinting in Otolaryngology: A Review.Advanced healthcare materials · 2023
    Review
  10. Emerging Progress of RNA-Based Antitumor Therapeutics.International journal of biological sciences · 2023
    Review
  11. Review
  12. 4D Cell-Condensate Bioprinting.Small (Weinheim an der Bergstrasse, Germany) · 2022
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Alexandra McMillanDepartment of Pathology, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA.
Minh Khanh NguyenDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA.
Cong Truc HuynhDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA; Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA.
Samantha M SarettDepartment of Biomedical Engineering, Vanderbilt University, 2201 West End Ave, Nashville, TN 37235, USA.
Peilin GeDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA.
Melanie ChetverikovaDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA.
Kien NguyenDepartment of Molecular Biology and Microbiology, Case Western Reserve University School of Medicine, 10900 Euclid Ave. Cleveland, OH 44106, USA.
David GroshDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA.
Craig L DuvallDepartment of Biomedical Engineering, Vanderbilt University, 2201 West End Ave, Nashville, TN 37235, USA.
Eben AlsbergDepartment of Biomedical Engineering, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA; Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA; Department of Orthopaedic Surgery, Case Western Reserve University, 10900 Euclid Ave. Cleveland, OH 44106, USA; Department of Pharmacology, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Orthopaedics, University of Illinois at Chicago, Chicago, IL 60612, USA; Department of Mechanical and Industrial Engineering, University of Illinois at Chicago, Chicago, IL 60607, USA; School of Dentistry, Kyung Hee University, Seoul, South Korea. Electronic address: ealsberg@uic.edu.
Case Western Reserve University · USVanderbilt University · USKyung Hee University · KRUniversity of Illinois Chicago · USUniversity School · US

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Substrate Mediated siRNA Delivery from Scaffolds to Promote Wound RepairR01EB019409 · NIBIB · VANDERBILT UNIVERSITY · PI Craig Lewis Duvall · 2014 to 2026
$4.0M
NRSA Training CoreTL1TR002549 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI HARDING, CLIFFORD V · 2018 to 2022
$2.9M
Engineering a Self-assembled, multi-tissue Tracheal ReplacementR01EB023907 · NIBIB · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALSBERG, EBEN, ROLLE, MARSHA W · 2017 to 2020
$1.9M
Opposing RNAi Molecule Gradient Constructs to Repair Osteochondral DefectsR01AR069564 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALSBERG, EBEN · 2016 to 2021
$1.8M
Driving Tissue Formation by Inductive Stem Cell Sheet TechnologyR01AR063194 · NIAMS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI ALSBERG, EBEN · 2012 to 2016
$1.7M
NCATS NIH HHS TL1 TR002549NIAMS NIH HHS R01 AR063194NIAMS NIH HHS R01 AR069564NIBIB NIH HHS R01 EB019409NIBIB NIH HHS R01 EB023907NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

Delivery systems for controlled release of RNA interference (RNAi) molecules, including small interfering (siRNA) and microRNA (miRNA), have the potential to direct stem cell differentiation for regenerative musculoskeletal applications. To date, localized RNA delivery platforms in this area have focused predominantly on bulk scaffold-based approaches, which can interfere with cell-cell interactions important for recapitulating some native musculoskeletal developmental and healing processes in tissue regeneration strategies. In contrast, scaffold-free, high density human mesenchymal stem cell (hMSC) aggregates may provide an avenue for creating a more biomimetic microenvironment. Here, photocrosslinkable dextran microspheres (MS) encapsulating siRNA-micelles were prepared via an aqueous emulsion method and incorporated within hMSC aggregates for localized and sustained delivery of bioactive siRNA. siRNA-micelles released from MS in a sustained fashion over the course of 28 days, and the released siRNA retained its ability to transfect cells for gene silencing. Incorporation of fluorescently labeled siRNA (siGLO)-laden MS within hMSC aggregates exhibited tunable siGLO delivery and uptake by stem cells. Incorporation of MS loaded with siRNA targeting green fluorescent protein (siGFP) within GFP-hMSC aggregates provided sustained presentation of siGFP within the constructs and prolonged GFP silencing for up to 15 days. This platform system enables sustained gene silencing within stem cell aggregates and thus shows great potential in tissue regeneration applications. STATEMENT OF SIGNIFICANCE: This work presents a new strategy to deliver RNA-nanocomplexes from photocrosslinked dextran microspheres for tunable presentation of bioactive RNA. These microspheres were embedded within scaffold-free, human mesenchymal stem cell (hMSC) aggregates for sustained gene silencing within three-dimensional cell constructs while maintaining cell viability. Unlike exogenous delivery of RNA within culture medium that suffers from diffusion limitations and potential need for repeated transfections, this strategy provides local and sustained RNA presentation from the microspheres to cells in the constructs. This system has the potential to inhibit translation of hMSC differentiation antagonists and drive hMSC differentiation toward desired specific lineages, and is an important step in the engineering of high-density stem cell systems with incorporated instructive genetic cues for application in tissue regeneration.

Indexed as

HydrogelsMesenchymal Stem CellsCell DifferentiationGene ExpressionGene SilencingHumansMicrospheresRNA, Small InterferingHydrogelsRNA, Small InterferingAggregatesGene therapyMesenchymal stem cellsRNA interferenceSustained delivery

Identifiers

PMID33465507
PMCPMC7990721
OpenAlexW3123033475

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.